We are live on ! Find out more
CF

CNA Financial Portfolio holdings

AUM $235M
1-Year Est. Return 3.39%
This Fund
S&P 500
This Quarter Est. Return
+9.01%
1 Year Est. Return
+3.39%
3 Year Est. Return
+50.54%
5 Year Est. Return
+66.93%
10 Year Est. Return
+254.04%
AUM
$383M
AUM Growth
+$15.4M
Cap. Flow
-$9.21M
Cap. Flow %
-2.41%
Top 10 Hldgs %
27.84%
Holding
206
New
13
Increased
73
Reduced
61
Closed
14

Top Buys

Rank Stock Value
1
WSO icon
Watsco Inc
WSO
+$2.96M
2
EPD icon
Enterprise Products Partners
EPD
+$2.8M
3
WDC icon
Western Digital
WDC
+$2.59M
4
FISV
Fiserv Inc
FISV
+$2.59M
5
BMY icon
Bristol-Myers Squibb
BMY
+$1.76M

Top Sells

Rank Stock Value
1
LEA icon
Lear
LEA
+$6.26M
2
PGR icon
Progressive
PGR
+$5.65M
3
NOC icon
Northrop Grumman
NOC
+$5.4M
4
PFE icon
Pfizer
PFE
+$2.48M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.44M

Sector Composition

Rank Sector Weight
1 Technology 24.18%
2 Healthcare 21.57%
3 Consumer Discretionary 11.54%
4 Industrials 10.78%
5 Financials 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPC
176
Ridgepost Capital
RPC
$1.01B
$372K 0.1%
+26,608
New +$351K
SHCO
177
DELISTED
Soho House & Co
SHCO
$362K 0.09%
28,287
– –
PRAX icon
178
Praxis Precision Medicines
PRAX
$8.5B
$359K 0.09%
1,215
+92
+8% +$27K
ADCT icon
179
ADC Therapeutics
ADCT
$134M
$308K 0.08%
15,245
+440
+3% +$10.6K
TWST icon
180
Twist Bioscience
TWST
$6.15B
$300K 0.08%
3,879
-4,460
-53% -$458K
YMAB
181
DELISTED
Y-mAbs Therapeutics
YMAB
$296K 0.08%
18,230
+4,470
+32% +$95.5K
GH icon
182
Guardant Health
GH
$21.8B
$293K 0.08%
2,928
– –
BTAI icon
183
BioXcel Therapeutics
BTAI
$26.1M
$292K 0.08%
897
+267
+42% +$115K
ERAS icon
184
Erasca
ERAS
$6.2B
$266K 0.07%
17,077
+2,940
+21% +$50.3K
CYRX icon
185
CryoPort
CYRX
$773M
$255K 0.07%
4,313
– –
SGHT icon
186
Sight Sciences
SGHT
$304M
$246K 0.06%
14,027
+1,180
+9% +$25.9K
ANNX icon
187
Annexon
ANNX
$855M
$226K 0.06%
19,710
+2,790
+16% +$45.1K
JAMF
188
DELISTED
Jamf
JAMF
$222K 0.06%
5,837
-12,235
-68% -$474K
RSKD icon
189
Riskified
RSKD
$702M
$182K 0.05%
23,216
+410
+2% +$5.86K
LIAN
190
DELISTED
LianBio American Depositary Shares
LIAN
$99K 0.03%
+15,993
New +$183K
TLMD
191
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$77K 0.02%
60,300
– –
XWEL icon
192
XWELL
XWEL
$9.12M
$63K 0.02%
1,568
– –
ALLK
193
DELISTED
Allakos
ALLK
– –
-6,330
Closed -$670K
ALLO icon
194
Allogene Therapeutics
ALLO
$628M
– –
-17,476
Closed -$449K
ARRY icon
195
Array Technologies
ARRY
$863M
– –
-26,589
Closed -$492K
BROS icon
196
Dutch Bros
BROS
$8.96B
– –
-6,126
Closed -$265K
BYSI icon
197
BeyondSpring
BYSI
$48.1M
– –
-19,764
Closed -$311K
LEA icon
198
Lear
LEA
$6.38B
– –
-40,000
Closed -$6.26M
NOC icon
199
Northrop Grumman
NOC
$77.7B
– –
-15,000
Closed -$5.4M
OLLI icon
200
Ollie's Bargain Outlet
OLLI
$4.56B
– –
-8,578
Closed -$517K
5 6 7
8
9

Similar funds

JRPCML
J. R. Prunier Capital Management LLC Holden, Massachusetts $235M AUM
CWL
Causey Wealth LLC Greenwood Village, Colorado $236M AUM 14.5% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
BWM
Bernard Wealth Management Royal Oak, Michigan $234M AUM 27.82% 1-Year Est. Return
GCM
Gables Capital Management Miami, Florida $236M AUM 32.91% 1-Year Est. Return
RP
Raelipskie Partnership Waterloo, Ontario, Canada $236M AUM 19.33% 1-Year Est. Return
HWMT
Heritage Wealth Management (Texas) Houston, Texas $234M AUM 15.67% 1-Year Est. Return
SP
Saranac Partners London $234M AUM 14.11% 1-Year Est. Return

CNA Financial's Q4 2021 Portfolio in Review

As of Q4 2021, CNA Financial held 206 positions worth $383M, up 4.2% from $367M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

CNA Financial's Q4 2021 filing shows 13 new, 73 increased, 61 reduced and 14 closed positions. Its largest new stake was Watsco Inc: 10,000 shares worth $3.13M. The largest sale was Lear, an estimated $6.26M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • CNA Financial's largest Q4 2021 buy was Watsco Inc: 10,000 shares worth $3.13M.
  • CNA Financial added most to Enterprise Products Partners in Q4 2021, an estimated $2.8M increase.
  • CNA Financial's biggest Q4 2021 reduction was Pfizer, cutting an estimated $2.48M.
  • CNA Financial fully exited Lear in Q4 2021, selling an estimated $6.26M.
  • CNA Financial's ten largest holdings make up 28% of its $383M portfolio in Q4 2021.
  • CNA Financial opened 13 new positions and closed 14 in Q4 2021.
  • CNA Financial's portfolio value rose 4.2% quarter-over-quarter to $383M.

Based on CNA Financial's 13F filing for Q4 2021, filed 11 Feb 2022.